When comparing AD with NAD subjects, the numbers of GPR162+, pTau217+ EVs were fewer in AD than those in NAD, while the number of GABRD+ EVs was the opposite (Fig. 4a–b, e–f). This evidence concerns the gene GPR162 and Alzheimer disease.